Navigation Links
Perrigo Reports Record Revenue and Adjusted Earnings
Date:5/7/2013

ALLEGAN, Mich., May 7, 2013 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE: PRGO) today announced results for its third quarter ended March 30, 2013.

(Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO )

Perrigo's Chairman and CEO Joseph C. Papa commented, "We are very pleased with our performance, as the team delivered all-time record quarterly revenue and adjusted diluted earnings per share. It was a very busy quarter for the team. We signed and closed the acquisition of Rosemont Pharmaceuticals, a specialty and generic prescription pharmaceutical company focused on the manufacturing and marketing of oral liquid formulations. We shipped Guaifenesin 600mg Extended-Release tablets with $135 million in branded sales. It is the first product that is generically equivalent to Mucinex® 600mg Extended-Release tablets. We launched the generic equivalents of Luxiq® Foam and Nicorette® mini lozenges and the authorized generic of Acetadote® injection. Finally, we filed an ANDA for the generic equivalent of Androgel® 1.62% and we believe we are the first to file. After the quarter ended, we closed our acquisition of Velcera, further expanding our recent entry into companion animal health and broadening our product offering. All of these great milestones were achieved while expanding margins in a record sales quarter." 

Refer to Table I at the end of this press release for adjustments in the current year and prior year periods and additional non-GAAP information. The Company's reported results are summarized in the attached Condensed Consolidated Statements of Income, Balance Sheets and Cash Flows.

  

Perrigo Company(in thousands, except per share amounts)(see the attached Tables I and IV for reconciliation to GAAP numbers
'/>"/>

SOURCE Perrigo Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine technology :

1. Perrigo Company To Release Third Quarter Fiscal Year 2013 Results On May 7, 2013
2. Perrigo Company To Present At The Barclays Global Healthcare Conference
3. Perrigo Company To Present At The RBC Global Healthcare Conference
4. Perrigo Confirms First to File Patent Challenge for Generic Version of Testosterone Gel 1.62%
5. Perrigo Company To Present At The Leerink Swann Global Healthcare Conference
6. Perrigo Company Acquires U.K.-based Rosemont Pharmaceuticals Ltd. For Approximately £180 Million Or $283 Million
7. Perrigo Confirms FDA Approval For Testosterone Gel 1%
8. Perrigo Reports Record Second Quarter Revenue, Adjusted Earnings and Operating Cash Flow
9. Perrigo Company To Acquire OTC Companion Animal Health Company, Velcera, Inc., For $160 Million
10. Perrigo Commences Launch Of Clobetasol Emulsion Propionate Foam, 0.05%
11. Perrigo Company To Release Second Quarter Fiscal Year 2013 Results On February 1, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 2014  Luminex Corporation (Nasdaq: LMNX ) today announced ... of 2013 on Monday, February 3, 2014. A press release ... of trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) ... operating highlights and financial results for the fourth quarter and ...
(Date:1/14/2014)... 14, 2014 Dynamic Healthcare Services, Inc. ("DHS"), a portfolio ... acquired Progressive Home Medical Equipment, Inc. ("Progressive") of ... of the acquisition were not disclosed. Progressive ... a wide range of sleep, mobility, and respiratory products to ...
(Date:1/14/2014)... 2014   NuAire , a manufacturer of ergonomically designed laboratory ... Koki of Japan to sell and ... . NuAire will utilize its network of sales professionals throughout ... to offer assistance in application use, product benefits and ...
Breaking Medicine Technology:Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3NuAire announces sales and service of Hitachi Koki centrifuges in North America 2
(Date:4/18/2014)... news release is available in French . ... could revolutionize surgical practice and regenerative medicine. A team ... et Chimie (CNRS/ESPCI Paris Tech) and Didier Letourneur from ... Paris 13), has just demonstrated that the principle of ... in vivo to repair soft-tissue organs and tissues. This ...
(Date:4/17/2014)... Men who show signs of chronic inflammation in non-cancerous ... actually having prostate cancer than those with no inflammation, ... researchers from the Johns Hopkins Kimmel Cancer Center. , ... stronger for men with so-called high-grade prostate cancer ... indicating the presence of the most aggressive and ...
(Date:4/17/2014)... Ill. One of the most popular vaccine brands ... And doctors may be overlooking some cost factors when ... a more expensive option, according to a new study ... vaccines to administer can be driven by numerous factors," ... and a professor of computer science and of mathematics ...
(Date:4/17/2014)... Diego School of Medicine report that older women, plucky ... loss are more likely to be compassionate toward strangers ... in this month,s issue of the International Journal ... associated with better health and well-being as we age, ... the outcomes of individuals whose deficits in compassion put ...
(Date:4/17/2014)... Pediatrician-in-Chief Jon McCullers, MD, was recently invited to ... Nature Reviews Microbiology , one of the ... world-renowned infectious disease specialist, and chair of the ... Health Science Center, analyzed the epidemiology and microbiology ... pandemics, as well as more recent 2009 novel ...
Breaking Medicine News(10 mins):Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:The ilk of human kindness 2
... In a study that could point to novel therapies to ... California, San Diego (UCSD) School of Medicine have targeted ... ,Lung cancer is the most common cause of ... metastasis are desperately needed, according to first author Mark M. ...
... from the SCIAMACHY instrument aboard ESAs environmental satellite ... hovering over Australia during the wildfire season ... 000 kilometres away. , ,Using SCIAMACHY, ... Research and her colleagues at Utrecht University, the ...
... and Drug Administration, the Purdue pharma of the US ... their popular painkiller Oxycontin. ,They have agreed to ... drug to boost sales and also pleaded guilty to charges ... ,Purdue pleaded guilty to a felony count of misbranding a ...
... ducks from Matigara, Darjeeling District in West Bengal & Kuttanad ... & H7) as per report received from High Animal Security ... been reported from these two places. ,In ... in death of 2500 birds on 5-6th May, 2007. A ...
... foods such as peanuts, tree nuts, milk and more ... to open a new clinic that will include a focus ... Dominos Farms in north Ann Arbor offers an expansion of ... Specialty Clinic and Food Allergy Clinic will be a regional ...
... Mental Health of the National Institutes of Health has ... research grant to test schizophrenic patients for a ... is led by Stephen T. Warren, PhD, Timmie Professor ... ,Schizophrenia is a severe and common psychiatric disorder ...
Cached Medicine News:Health News:Targeting Sugar on Blood Vessels may Inhibit Cancer Growth 2Health News:Transcontinental Wildfire Emissions Monitored from Space 2Health News:US Drugmaker Slapped Huge Fine for Misleading Doctors Over Addictive Painkiller 2Health News:NIH Awards Emory $3.6 Million for Schizophrenia Gene Research 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: